这就是成都: Today’s stock pick update

2020年8月31日星期一

On September 2, the Truth Will Come Out…

A millionaire trading expert will lay all his cards on the table...And reveal how anybody with a computer, a mouse and half a brain could’ve turned $5,000 into as much as $53,150 in just three weeks! It’s all happening LIVE at 1 p.m. on September 2. (Ad)

Claim your ticket to this FREE event now...

Buffett’s Berkshire Hathaway Is Betting Big On These 5 Japanese Companies

As confirmed coronavirus cases in the U.S. near 6 million, the head of the FDA promised over the weekend that the review of a potential COVID-19 vaccine in the U.S. will be transparent to the public, with any clearance by the agency driven by data alone. Commissioner Stephen Hahn said in an interview on Sunday that the FDA could clear a vaccine for use either under an emergency use authorization based on more limited data and for use in a narrow group should a company apply f...

Read More

Calix Inc (NYSE: CALX): Calix shares got a boost late last week after announcing that Cumberland Connect, a subsidiary of one of the largest electric cooperatives in the U.S., has partnered with it to simultaneously deliver fiber broadband connections and the Revenue EDGE ultimate subscriber experiment to Cumberland’s entire membership base. “Electric cooperatives tend to be ag...

Read More

PVH is up more than 17% in the last month, but still down -25% for the year. What is its value?

The natural temptation if you’re using the performance of one sector versus another to inform your investing decisions is to gravitate to the top-performing sectors; it’s a reasonable variation of the trend-following mindset that “a rising tide lifts all ships.” As a value-oriented investor with more than a little bit of a contrarian bent, however, I often find myself looking at out-of-favor sectors to find good companies that offer terrific value.

Featured Stock

Eton Pharmaceuticals, Inc. (ETON) -Buy Price: $8.00 or better

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products. The company offers Biorphen, a phenylephrine hydrochloride injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia.